Viatris (VTRS) Accounts Payables (2019 - 2026)
Viatris (VTRS) recorded quarterly Accounts Payables of $1.7 billion in Q1 2026, little changed quarter-over-quarter from $1.8 billion in Q4 2025, and down 12.02% on a YoY basis from $2.0 billion in Q1 2025.
Viatris (VTRS) Accounts Payables (2019 - 2026) Analysis & Trends
Viatris' Accounts Payables history runs 8 years deep, the most recent figure standing at $1.7 billion for Q1 2026.
- In Q1 2026, Accounts Payables fell 12.02% year-over-year to $1.7 billion; the TTM figure through Mar 2026 stood at $1.7 billion (down 12.02% YoY), while the FY2025 annual figure was $1.8 billion, down 5.37% from the prior year.
- Accounts Payables was $1.7 billion for Q1 2026 at Viatris, roughly flat from $1.8 billion in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $2.2 billion in Q1 2024 to a low of $1.3 billion in Q3 2022.
- Historically, Accounts Payables has averaged $1.8 billion across 5 years, with a median of $1.9 billion in 2024.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables fell 26.61% in 2022, then soared 51.78% in 2023.
- A 5-year view of Accounts Payables shows it stood at $1.8 billion in 2022, then advanced by 9.71% to $1.9 billion in 2023, then decreased by 4.36% to $1.9 billion in 2024, then retreated by 5.37% to $1.8 billion in 2025, then dropped by 0.27% to $1.7 billion in 2026.
- The last three Accounts Payables figures came in at $1.7 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 45.88 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 306.87 Mn |
| 10 | Viatris | - | - | 1.16 Bn | 1.75 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.75 Bn |
| Dec 31, 2025 | 1.75 Bn |
| Sep 30, 2025 | 1.79 Bn |
| Jun 30, 2025 | 1.78 Bn |
| Mar 31, 2025 | 1.99 Bn |
| Dec 31, 2024 | 1.85 Bn |
| Sep 30, 2024 | 1.93 Bn |
| Jun 30, 2024 | 1.96 Bn |
| Mar 31, 2024 | 2.20 Bn |
| Dec 31, 2023 | 1.94 Bn |
| Sep 30, 2023 | 1.99 Bn |
| Jun 30, 2023 | 1.96 Bn |
| Mar 31, 2023 | 1.96 Bn |
| Dec 31, 2022 | 1.77 Bn |
| Sep 30, 2022 | 1.31 Bn |
| Jun 30, 2022 | 1.67 Bn |
| Mar 31, 2022 | 1.50 Bn |
| Dec 31, 2021 | 1.66 Bn |
| Sep 30, 2021 | 1.66 Bn |
| Jun 30, 2021 | 1.80 Bn |